Cytological Sub-Classification of Atypia of Undetermined Significance May Predict Malignancy Risk in Thyroid Nodules | Citedby Results | Acta Cytologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Cytological Sub-Classification of Atypia of Undetermined Significance May Predict Malignancy Risk in Thyroid Nodules

Acta Cytologica (2021) 65 (3): 205–212.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Cytologic assessment of thyroid nodules – Updates in 2023 Bethesda reporting system, diagnostic challenges and pitfalls

Xiaobing Jin
Xin Jing

Human Pathology Reports (2024) 36: 300743.

Performance of Afirma genomic sequencing classifier and histopathological outcome in Bethesda category III thyroid nodules: Initial versus repeat fine‐needle aspiration

Xiaobing Jin
Madelyn Lew
Liron Pantanowitz
Jennifer J. Iyengar
Megan R. Haymart
Maria Papaleontiou
David Broome
Zahrae Sandouk
Sobia S. Raja
David T. Hughes
Brian Smola
Xin Jing

Diagnostic Cytopathology (2023) 51 (11): 698.

Use of molecular testing results to analyze the overuse of atypia of undetermined significance in thyroid cytology

Daniel Martinez Coconubo
Joshua J. Levy
Darcy A. Kerr
Louis J. Vaickus
Laura Vidis
Ryan E. Glass
Edward J. Gutmann
Jonathan D. Marotti
Xiaoying Liu

Journal of the American Society of Cytopathology (2023) 12 (6): 451.

Management of thyroid nodules

Erik K Alexander
Gerard M Doherty
Justine A Barletta

The Lancet Diabetes & Endocrinology (2022) 10 (7): 540.